GSK to produce in Brasov a medicine for HIV treatment
The medicine is to be exported as of 2011 and it is the second drug whose production has been transferred from other plants of the company to the Romania-based facility.
‘Besides Seroxat (antidepressant), our plant from Brasov will manage the production transfer for Retrovir tablets, a treatment for the HIV/AIDS. The project has already started, the production tests and the quality control being schedules for the end of this year.
The first exports are scheduled to start in Q1 of 2011, after the conclusion of registration procedures,’ said the general manager of GSK Romania, Patrick Desbiens.
Until 2011, the company estimates that 10 million tablets of Retrovir will be produced in the Brasov-based plant.